Respiratory and sleep disorders in mucopolysaccharidosis

Kenneth I Berger1, Simone C Fagondes, Roberto Giugliani

  • 1Department Medicine, Physiology and Neuroscience, André Cournand Pulmonary Physiology Laboratory, Bellevue Hospital, New York University School of Medicine, New York, NY, USA. Kenneth.Berger@nyumc.org

Insights

Mucopolysaccharidoses (MPS) cause glycosaminoglycan (GAG) buildup, leading to common ear, nose, throat (ENT), and respiratory issues. This review details these manifestations and their management in MPS patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Mucopolysaccharidoses (MPS) are rare genetic lysosomal storage disorders.
  • Characterized by the accumulation of glycosaminoglycans (GAGs) in various tissues.
  • This accumulation leads to progressive multi-systemic clinical manifestations.

Purpose of the Study:

  • To provide a comprehensive overview of Ear, Nose, and Throat (ENT) and respiratory problems in MPS.
  • To discuss the evaluation and management strategies for these manifestations.
  • To highlight the early and common occurrence of ENT and respiratory symptoms in MPS patients.

Main Methods:

  • Literature review of existing studies on MPS.
  • Analysis of clinical manifestations related to ENT and respiratory systems.
  • Discussion of diagnostic and therapeutic approaches.

Main Results:

  • ENT and respiratory issues are highly prevalent in MPS, often presenting early.
  • Common manifestations include airway obstruction, restrictive pulmonary disease, chronic infections, and sleep apnea.
  • These symptoms significantly impact quality of life and can lead to severe complications like respiratory failure.

Conclusions:

  • ENT and respiratory problems are critical components of MPS clinical presentation.
  • Timely evaluation and appropriate management are essential for improving patient outcomes.
  • Further research into specialized interventions for these manifestations is warranted.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...